S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for Onconetix, Inc. [ONCO]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
Last Updated17 May 2024 @ 16:00

10.64% $ 0.156

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide...

Stats
Today's Volume 15.66M
Average Volume 404 356
Market Cap 3.48M
EPS $0 ( 2024-05-12 )
Next earnings date ( $0 ) 2024-05-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0.00100 (0.62%)
Insider Trading
Date Person Action Amount type
2024-02-16 Singh Ajit Buy 3 125 Common Stock
2024-02-08 Singh Ajit Buy 0
2024-02-06 Meier Thomas Buy 0
2003-12-05 Liberty Media Corp /de/ Sell 22 897 677 Common Stock
INSIDER POWER
100.00
Last 2 transactions
Buy: 3 125 | Sell: 22 897 677

Volume Correlation

Long: -0.08 (neutral)
Short: -0.32 (neutral)
Signal:(64.826) Neutral

Onconetix, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Onconetix, Inc. Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.51
( weak )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.13
( neutral )

Onconetix, Inc. Financials

Annual 2023
Revenue: $58 465.00
Gross Profit: $-1.14M (-1 950.17 %)
EPS: $-2.19
FY 2023
Revenue: $58 465.00
Gross Profit: $-1.14M (-1 950.17 %)
EPS: $-2.19

Financial Reports:

No articles found.

Onconetix, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Onconetix, Inc.

Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators